Trial Outcomes & Findings for STAMP+CBT mHealth for Cancer Pain (NCT NCT05403801)

NCT ID: NCT05403801

Last Updated: 2025-01-01

Results Overview

\>70% of subjects complete \>4 of the 6 pain-CBT modules and patients will complete 50% of surveys by the end of 4 weeks (completion of the 4-week intervention study period)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

10 participants

Primary outcome timeframe

4 Weeks

Results posted on

2025-01-01

Participant Flow

Patients were recruited from outpatient palliative care clinics

Participant milestones

Participant milestones
Measure
Pilot Cohort
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
Overall Study
STARTED
10
Overall Study
COMPLETED
8
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Pilot Cohort
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
Overall Study
Withdrawal by Subject
2

Baseline Characteristics

STAMP+CBT mHealth for Cancer Pain

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Pilot Cohort
n=8 Participants
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
Age, Continuous
52 Years
STANDARD_DEVIATION 9.6 • n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
Race (NIH/OMB)
White
7 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
8 participants
n=5 Participants

PRIMARY outcome

Timeframe: 4 Weeks

Population: Participants who tested the app for 4 weeks (n=8) completed daily their daily EMA surveys.

\>70% of subjects complete \>4 of the 6 pain-CBT modules and patients will complete 50% of surveys by the end of 4 weeks (completion of the 4-week intervention study period)

Outcome measures

Outcome measures
Measure
Pilot Cohort
n=28 Total EMA App Surveys
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
Overall Intervention Adherence Rate
15.75 EMA App Surveys
Standard Deviation 6.76

PRIMARY outcome

Timeframe: 4 weeks

Population: Evaluate each acceptability items that were rated as 4 or higher out of 5 for all patients

Participants completed a modified version of the Acceptability E-scale, rating the app on a 5-point Likert scale (1-5), across 5 unique items on the following 5 domains: understandability, enjoyability, ease of use, time required to use it, and overall satisfaction.\[Tariman, 2011\] Higher scores indicated greater acceptability. Acceptability was pre-defined as \>80% across all acceptability items rated as \>4 or higher out of 5. Acceptability was evaluated by determining the mean score of all items for all participants (range of scale of score 1-5).

Outcome measures

Outcome measures
Measure
Pilot Cohort
n=8 Participants
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
Acceptability Rate
4.26 scores on a scale
Standard Deviation 1.07

SECONDARY outcome

Timeframe: 7 Months

Population: 10 patients were recruited in 7 months and 8 remained in the study and completed all study activities and measures.

Participants were defined as individuals who consented and enrolled in the trial and completed 28 days of app use and completed study measures.

Outcome measures

Outcome measures
Measure
Pilot Cohort
n=10 Participants
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
Number of Enrolled Participants Who Consented and Completed the Study
8 participants

SECONDARY outcome

Timeframe: 6 Months

Population: Percent of patients who consented and also completed 4 weeks of app use and surveys at 4 and 6 weeks after enrollment

The goal of the study was to have 60% of patients who enroll to the app will complete app use (use the app for 28 days) at the end of the 4 weeks and surveys at 4 and 6 weeks after enrollment

Outcome measures

Outcome measures
Measure
Pilot Cohort
n=10 Participants
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
Study Retention
8 Participants

SECONDARY outcome

Timeframe: 6 Weeks

Population: Patients rated the app's perceived acceptability on understandability, enjoyability, ease of use, time required to use it, and overall satisfaction on a 5-point Likert scale.

Overall acceptability will be determined based on composite evaluation of acceptability ratings using the modified items from the Acceptability E-Scale \[Tariman 2011\]. Participants completed a modified version of the Acceptability e-scale, rating the app on a 5-point Likert scale on the following 5 domains: understandability, enjoyability, ease of use, time required to use it, and overall satisfaction. Higher scores indicated higher acceptability. Acceptability was pre-defined as \>80% of all acceptability items being rated individually as \>4 out of 5 (possible scores on this scale range between 1-5). Acceptability was evaluated by determining the mean score on each item individually, across all participants (range of scale of score 1-5).

Outcome measures

Outcome measures
Measure
Pilot Cohort
n=8 Participants
Patients will use the STAMP+CBT app for 4 weeks (or 6 weeks if they request to review content further). During this 4 week intervention period participants will engage in pain CBT content including a goal-setting module, relaxation exercises, and reviewing educational content on cancer pain and psychological concepts. Patients will also use the app daily to report symptoms or pain, catastrophizing, mood, and sleep, and their usage of prescribed opioid medications. Patients will complete survey assessments at baseline, 4 weeks (end of intervention period), and 6 weeks (end of 2-week post intervention period) assessing feasibility, acceptability, and usability of the of the STAMP+CBT app.
COMPREHENSIVE ENDPOINT
Ease of use
4.29 scores on a scale
Standard Deviation 0.45
COMPREHENSIVE ENDPOINT
Understandability
5.0 scores on a scale
Standard Deviation 0
COMPREHENSIVE ENDPOINT
Enjoyability
4.14 scores on a scale
Standard Deviation 0.64
COMPREHENSIVE ENDPOINT
Time acceptability
4.14 scores on a scale
Standard Deviation 0.99
COMPREHENSIVE ENDPOINT
overall Satisfaction
4.29 scores on a scale
Standard Deviation 0.45

Adverse Events

Pilot Cohort

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Desiree Azizoddin

Dana Farber Cancer Institute

Phone: (617) 632-3000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place